DaVita expands board to nine, appoints Dr. Gregory J. Moore as director

DAVITA INC.

Board size increased from 8 to 9 members effective September 9, 2021.
Gregory J. Moore, M.D., Ph.D. appointed to fill new vacancy; also joins Nominating and Governance and Compliance and Quality Committees.
Dr. Moore will receive standard non-employee director compensation and indemnification; no material transactions with the company.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Gregory J. Moore

Director

DVA · DAVITA INC.

Effective: 2021-09-09
Filed: September 9, 2021, 7:59 PM ET

appointed Gregory J. Moore, M.D., Ph.D. as a member of the Board, to fill the newly created vacancy on the Board, in each case effective as of September 9, 2021.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Gregory J. Moore was appointed as Director at DAVITA INC..

Action: appointed
Role: Director

Exact text from the filing

appointed Gregory J. Moore, M.D., Ph.D. as a member of the Board, to fill the newly created vacancy on the Board, in each case effective as of September 9, 2021.

View on SEC.gov

DAVITA INC. filing history →

Source: SEC EDGAR

accession 0000927066-21-000159

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.